SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-016738
Filing Date
2021-03-30
Accepted
2021-03-30 17:22:33
Documents
16
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 20-F sln-20f_20201231.htm 20-F 5767657
2 EX-2.3 sln-ex23_100.htm EX-2.3 210045
3 EX-2.4 sln-ex24_101.htm EX-2.4 92147
4 EX-12.1 sln-ex121_105.htm EX-12.1 11164
5 EX-12.2 sln-ex122_106.htm EX-12.2 11217
6 EX-13.1 sln-ex131_103.htm EX-13.1 9926
7 EX-13.2 sln-ex132_104.htm EX-13.2 9977
8 EX-23.1 sln-ex231_102.htm EX-23.1 2176
9 GRAPHIC geuffjicdhlm000002.jpg GRAPHIC 168671
10 GRAPHIC geuffjicdhlm000005.jpg GRAPHIC 105112
11 GRAPHIC geuffjicdhlm000006.jpg GRAPHIC 16126
12 GRAPHIC geuffjicdhlm000008.jpg GRAPHIC 72018
13 GRAPHIC geuffjicdhlm000003.jpg GRAPHIC 75930
14 GRAPHIC geuffjicdhlm000001.jpg GRAPHIC 68926
15 GRAPHIC geuffjicdhlm000004.jpg GRAPHIC 12601
16 GRAPHIC geuffjicdhlm000007.jpg GRAPHIC 263285
  Complete submission text file 0001564590-21-016738.txt   7193519
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: 20-F | Act: 34 | File No.: 001-39487 | Film No.: 21788088
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences